Addex Therapeutics
ADXN
5 hedge funds and large institutions have $5.42M invested in Addex Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0.03% less ownership
Funds ownership: 0.11% → 0.08% (-0.03%)
12% less capital invested
Capital invested by funds: $6.17M → $5.42M (-$753K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$258K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$79.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $2.89M | -$258K | -2,358 | -8% |
|
|
CC
2
Caxton Corporation
Princeton,
New Jersey
| $1.35M | – | – | – |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $914K | – | – | – |
|
|
NLVP
4
New Leaf Venture Partners
New York
| $254K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $14K | -$79.2K | -725 | -84% |
|
ADXN Hedge Fund Activity: Q1 2022 in Review
5 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q1 2022, worth a combined $5.42M — down 12% from $6.17M a quarter earlier.
Fund positioning in ADXN was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Armistice Capital, cutting an estimated $258K.
- 5 institutional investors held Addex Therapeutics (ADXN) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $5.42M of Addex Therapeutics stock for Q1 2022, down 12% quarter-over-quarter.
- 0 funds opened new Addex Therapeutics positions in Q1 2022 and 0 closed out.
- The largest Addex Therapeutics seller in Q1 2022 was Armistice Capital, an estimated $258K sold.
Based on aggregated 13F filings for Q1 2022.